Arca Biopharma | ABIO - Operating Expenses


Arca Biopharma reported $34.43M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Amgen USD 4.78B 1.12B Mar/2026
Arca Biopharma USD 34.43M 326K Dec/2025
Biogen USD 1.96B 69.6M Mar/2026
Brainstorm Cell Therapeutics USD 2.24M 197K Dec/2025
Bristol-Myers Squibb USD 20.07B 11.77B Mar/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cipla INR 59.27B 1.71B Mar/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.29M 1.51M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Cytokinetics USD 200.58M 4.46M Mar/2026
Daiichi Sankyo JPY 468.57B 15.34B Dec/2025
Gilead Sciences USD 23.52B 18.55B Mar/2026
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
Grifols EUR 1.99B 217.4M Dec/2025
Laboratory Of America USD 3.13B 6.3M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Otsuka Holdings JPY 512.13B 70.77B Mar/2026
Pfizer USD 90.1B 77.19B Mar/2026
United Therapeutics USD 5.9B 5.1B Mar/2026